Ibnsina Pharma (ISPH) Key Statistics
26 reported figures for Ibnsina Pharma — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 11.26B
- P/E (trailing)
- 13.14
- P/B
- 3.64
- Dividend yield (FY 2025)
- 2.59%
Income (latest fiscal year)
- Revenue
- EGP 76.6B
- Net income
- EGP 951.98M
- EBITDA
- EGP 3.95B
- Free cash flow
- EGP -805.66M
- Profit margin
- 1.24%
Balance sheet
- Total assets
- EGP 36.21B
- Total debt
- EGP 27.37B
- Book value
- EGP 2.88B
Growth
- Revenue growth
- 37.17%
- Profit growth
- 54.9%
- EPS growth
- 54.92%
Per share
- EPS (fiscal year)
- 0.77
- Book value per share
- 2.86
- Dividend per share
- 0.26
- Return on equity
- 39.54%
- Return on assets
- 2.94%
Technical
- RSI (14)
- 35.5
- 50-day moving average
- EGP 12.02
- 200-day moving average
- EGP 11.64
- Beta (1Y)
- 1.26
Shares
- Shares outstanding
- 1.12B
- Free float
- 65.08%
Fiscal-year figures are as the company last reported them; technical readings refresh with market data.